Ibritumomab Intravenous and Neoral (Cyclosporine Oral Solution, Modified)
Determining the interaction of Ibritumomab Intravenous and Neoral (Cyclosporine Oral Solution, Modified) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Neoral (Capsules, Modified), Neoral
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Neoral Oral
- Ibritumomab Intravenous-Neosar
- Ibritumomab Intravenous-Neosporin + Pain Relief Ointment
- Ibritumomab Intravenous-Neosporin AF Topical
- Ibritumomab Intravenous-Neosporin G.U
- Ibritumomab Intravenous-Neosporin G.U. Irrigant [DSC}
- Neoral (Cyclosporine Oral Solution, Modified)-Ibritumomab Tiuxetan
- Neoral (Cyclosporine Oral Solution, Modified)-Ibrutinib
- Neoral (Cyclosporine Oral Solution, Modified)-Ibrutinib Capsules
- Neoral (Cyclosporine Oral Solution, Modified)-Ibrutinib Tablets
- Neoral (Cyclosporine Oral Solution, Modified)-Ibu
- Neoral (Cyclosporine Oral Solution, Modified)-IBU Tablets